Compare use cases

Drop two or three slugs into the URL — for example ?slugs=demo-mia-breast-screening,demo-idx-dr-retinopathy — or pick from the validated catalogue below.

Pick from validated:

AI imaging triage for the acute stroke pathway AI second reader for breast cancer screening Autonomous diabetic retinopathy screening in primary care Pre-operative risk-stratification model for major surgery Self-referral assistant for NHS Talking Therapies Type-2 diabetes long-term outcome predictor

Clear selection

	AI second reader for breast cancer screening United Kingdom	AI imaging triage for the acute stroke pathway United Kingdom	Type-2 diabetes long-term outcome predictor Netherlands
Trust badge	Validated	Validated & replicable	Validated
Evidence strength	Emerging evidence	Developing evidence	Robust evidence
Pipeline stage	Validated	Scaled	Validated
Intended use	Acts as an independent second reader of screening mammograms to support the double-reading workflow and reduce reader workload without lowering cancer detection.	Interprets acute stroke imaging to support rapid identification of large-vessel occlusion and treatment eligibility, accelerating thrombectomy referral.	Estimates 5-year risk of major diabetes-related complications (cardiovascular, renal, retinal) from longitudinal primary-care records to support care-plan intensification.
Specialty	Radiology	Emergency medicine	Endocrinology
Autonomy	Informs a human (advisory)	Informs a human (advisory)	Informs a human (advisory)
Deployment	Active deployment	Scaling up	Active deployment
EU AI Act tier	High-risk	High-risk	High-risk
EU MDR class	Class IIb	Class IIb	Not a device
CE marking	CE marked	CE marked	Not required
NICE ESF tier	Tier C — treat / diagnose / calculate risk	Tier C — treat / diagnose / calculate risk	Tier C — treat / diagnose / calculate risk
Headline metric	Sensitivity: 0.91	Time saved: 60	AUC / AUROC: 0.82
Subgroup assessed	Yes	Yes	Yes